Group of 100 medical students took an end of the year exam. The mean score on the exam was 70%, with a standard deviation of 25%. The professor states that a student's score must be within the 95% confidence interval of the mean to pass the exam. Which of the following is the minimum score a student can have to pass the exam?
Q2
An at-home recreational drug screening test kit is currently being developed. They consult you for assistance with determining an ideal cut-off point for the level of the serum marker in the test kit. This cut-off point will determine what level of serum marker is associated with a positive or negative test, with serum marker levels greater than the cut-off point indicative of a positive test and vice-versa. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How will the sensitivity and specificity of the test change if the cut-off level is raised to 6 mg/uL?
Q3
A mother presents to the family physician with her 16-year-old son. She explains, "There's something wrong with him doc. His grades are getting worse, he's cutting class, he's gaining weight, and his eyes are often bloodshot." Upon interviewing the patient apart from his mother, he seems withdrawn and angry at times when probed about his social history. The patient denies abuse and sexual history. What initial test should be sent to rule out the most likely culprit of this patient's behavior?
Q4
A home drug screening test kit is currently being developed. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How might the sensitivity and specificity of the test change if the cut-off level is changed to 2 mg/uL?
Q5
An investigator is measuring the blood calcium level in a sample of female cross country runners and a control group of sedentary females. If she would like to compare the means of the two groups, which statistical test should she use?
Q6
You conduct a medical research study to determine the screening efficacy of a novel serum marker for colon cancer. The study is divided into 2 subsets. In the first, there are 500 patients with colon cancer, of which 450 are found positive for the novel serum marker. In the second arm, there are 500 patients who do not have colon cancer, and only 10 are found positive for the novel serum marker. What is the overall sensitivity of this novel test?
Q7
A pharmaceutical corporation is developing a research study to evaluate a novel blood test to screen for breast cancer. They enrolled 800 patients in the study, half of which have breast cancer. The remaining enrolled patients are age-matched controls who do not have the disease. Of those in the diseased arm, 330 are found positive for the test. Of the patients in the control arm, only 30 are found positive. What is this test’s sensitivity?
Q8
A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient’s concern?
Q9
A medical research study is beginning to evaluate the positive predictive value of a novel blood test for non-Hodgkin’s lymphoma. The diagnostic arm contains 700 patients with NHL, of which 400 tested positive for the novel blood test. In the control arm, 700 age-matched control patients are enrolled and 0 are found positive for the novel test. What is the PPV of this test?
Q10
You are tasked with analyzing the negative predictive value of an experimental serum marker for ovarian cancer. You choose to enroll 2,000 patients across multiple clinical sites, including both 1,000 patients with ovarian cancer and 1,000 age-matched controls. From the disease and control subgroups, 700 and 100 are found positive for this novel serum marker, respectively. Which of the following represents the NPV for this test?
Trade-offs between sensitivity and specificity US Medical PG Practice Questions and MCQs
Question 1: Group of 100 medical students took an end of the year exam. The mean score on the exam was 70%, with a standard deviation of 25%. The professor states that a student's score must be within the 95% confidence interval of the mean to pass the exam. Which of the following is the minimum score a student can have to pass the exam?
A. 45%
B. 63.75%
C. 67.5%
D. 20%
E. 65% (Correct Answer)
Explanation: ***65%***
- To find the **95% confidence interval (CI) of the mean**, we use the formula: Mean ± (Z-score × Standard Error). For a 95% CI, the Z-score is approximately **1.96**.
- The **Standard Error (SE)** is calculated as SD/√n, where n is the sample size (100 students). So, SE = 25%/√100 = 25%/10 = **2.5%**.
- The 95% CI is 70% ± (1.96 × 2.5%) = 70% ± 4.9%. The lower bound is 70% - 4.9% = **65.1%**, which rounds to **65%** as the minimum passing score.
*45%*
- This value is significantly lower than the calculated lower bound of the 95% confidence interval (approximately 65.1%).
- It would represent a score far outside the defined passing range.
*63.75%*
- This value falls below the calculated lower bound of the 95% confidence interval (approximately 65.1%).
- While close, this score would not meet the professor's criterion for passing.
*67.5%*
- This value is within the 95% confidence interval (65.1% to 74.9%) but is **not the minimum score**.
- Lower scores within the interval would still qualify as passing.
*20%*
- This score is extremely low and falls significantly outside the 95% confidence interval for a mean of 70%.
- It would indicate performance far below the defined passing threshold.
Question 2: An at-home recreational drug screening test kit is currently being developed. They consult you for assistance with determining an ideal cut-off point for the level of the serum marker in the test kit. This cut-off point will determine what level of serum marker is associated with a positive or negative test, with serum marker levels greater than the cut-off point indicative of a positive test and vice-versa. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How will the sensitivity and specificity of the test change if the cut-off level is raised to 6 mg/uL?
A. Sensitivity decreases, specificity decreases
B. Sensitivity decreases, specificity may increase or decrease
C. Sensitivity decreases, specificity increases (Correct Answer)
D. Sensitivity increases, specificity increases
E. Sensitivity increases, specificity decreases
Explanation: ***Sensitivity decreases, specificity increases***
- Raising the cut-off level means that the test will now require a **higher concentration of the serum marker** to be considered positive. This makes it harder for true positives to be identified (more false negatives), thus **decreasing sensitivity**.
- Conversely, a higher cut-off makes it less likely for healthy individuals (true negatives) to mistakenly test positive (fewer false positives), leading to an **increase in specificity**.
*Sensitivity decreases, specificity decreases*
- This option is incorrect because **raising the cut-off point** typically has opposing effects on sensitivity and specificity, not a decrease in both.
- A decrease in both would suggest a poorly designed or random change, which is not the expected outcome of systematically adjusting a threshold.
*Sensitivity decreases, specificity may increase or decrease*
- While it's true that real-world scenarios can be complex, for a single, direct change to a cut-off point, the relationship between sensitivity and specificity is generally inverse for a given test.
- The uncertainty implied by "may increase or decrease" does not fully capture the predictable inverse relationship that occurs when adjusting a diagnostic threshold.
*Sensitivity increases, specificity increases*
- **Increasing sensitivity** and **increasing specificity** simultaneously is only achievable by improving the diagnostic test itself (e.g., using a better marker), not by simply adjusting a fixed cut-off point.
- Adjusting a cut-off almost always involves a **trade-off** between these two metrics.
*Sensitivity increases, specificity decreases*
- This would occur if the cut-off level were **lowered**, not raised.
- A lower cut-off would detect more true positives (increased sensitivity) but would also incorrectly classify more healthy individuals as positive (decreased specificity).
Question 3: A mother presents to the family physician with her 16-year-old son. She explains, "There's something wrong with him doc. His grades are getting worse, he's cutting class, he's gaining weight, and his eyes are often bloodshot." Upon interviewing the patient apart from his mother, he seems withdrawn and angry at times when probed about his social history. The patient denies abuse and sexual history. What initial test should be sent to rule out the most likely culprit of this patient's behavior?
A. Complete blood count
B. Sexually transmitted infection (STI) testing
C. Blood culture
D. Urine toxicology screen (Correct Answer)
E. Slit lamp examination
Explanation: ***Urine toxicology screen***
- The patient's presentation with **declining grades**, **cutting class**, **weight gain**, **bloodshot eyes**, and **irritability** are classic signs of **substance abuse** in an adolescent.
- A **urine toxicology screen** is the most appropriate initial test to detect common illicit substances, especially given the clear signs pointing towards drug use.
*Slit lamp examination*
- This test is used to examine the **anterior segment of the eye**, including the conjunctiva, cornea, iris, and lens.
- While the patient has **bloodshot eyes**, this specific test would be more relevant for ruling out ocular infections or injuries, not for diagnosing the underlying cause of systemic behavioral changes.
*Complete blood count*
- A **complete blood count (CBC)** measures different components of the blood, such as red blood cells, white blood cells, and platelets.
- A CBC is a general health indicator and while it can detect infections or anemia, it is not specific or sensitive enough to identify the cause of the behavioral changes described.
*Sexually transmitted infection (STI) testing*
- Although the patient denies sexual history, all adolescents presenting with certain risk factors or symptoms may warrant STI testing in a broader health assessment.
- However, in this scenario, the primary cluster of symptoms (poor grades, cutting class, bloodshot eyes, irritability) points more directly to substance abuse than to an STI.
*Blood culture*
- A **blood culture** is used to detect the presence of bacteria or other microorganisms in the bloodstream, indicating a systemic infection (sepsis).
- The patient's symptoms are not indicative of an acute bacterial bloodstream infection, and a blood culture would not be the initial test for the presented behavioral changes.
Question 4: A home drug screening test kit is currently being developed. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How might the sensitivity and specificity of the test change if the cut-off level is changed to 2 mg/uL?
A. Sensitivity = 92%, specificity = 97%
B. Sensitivity = 95%, specificity = 98%
C. Sensitivity = 100%, specificity = 97%
D. Sensitivity = 90%, specificity = 99%
E. Sensitivity = 97%, specificity = 96% (Correct Answer)
Explanation: ***Sensitivity = 97%, specificity = 96%***
- Lowering the cut-off from 4 mg/uL to 2 mg/uL means that more individuals will be classified as **positive** (anyone with drug levels ≥2 mg/uL instead of ≥4 mg/uL). This change will **increase the sensitivity** (capturing more true positives, fewer false negatives) but **decrease the specificity** (more false positives among those without the condition).
- Therefore, sensitivity will increase (e.g., to 97%), and specificity will decrease (e.g., to 96%), reflecting the fundamental trade-off between these metrics.
*Sensitivity = 92%, specificity = 97%*
- This option reflects the **original values** at the 4 mg/uL cut-off and does not account for the change in the threshold.
- A change in the cut-off level will inherently alter the test's performance characteristics.
*Sensitivity = 95%, specificity = 98%*
- This option suggests an increase in **both sensitivity and specificity**, which is generally not possible by simply changing the cut-off level in the same direction.
- There is typically an **inverse relationship** between sensitivity and specificity when adjusting the cut-off threshold.
*Sensitivity = 100%, specificity = 97%*
- Reaching **100% sensitivity** while maintaining a high specificity is highly unlikely with a simple cut-off adjustment.
- While sensitivity would increase with a lower cut-off, achieving perfect sensitivity is unrealistic in clinical practice.
*Sensitivity = 90%, specificity = 99%*
- This option suggests a **decrease in sensitivity** and an **increase in specificity**.
- A lower cut-off would lead to more positive results, thus increasing sensitivity and reducing specificity, which contradicts the proposed values.
Question 5: An investigator is measuring the blood calcium level in a sample of female cross country runners and a control group of sedentary females. If she would like to compare the means of the two groups, which statistical test should she use?
A. Chi-square test
B. Linear regression
C. t-test (Correct Answer)
D. ANOVA (Analysis of Variance)
E. F-test
Explanation: ***t-test***
- A **t-test** is appropriate for comparing the means of two independent groups, such as the blood calcium levels between runners and sedentary females.
- It assesses whether the observed difference between the two sample means is statistically significant or occurred by chance.
*Chi-square test*
- The **chi-square test** is used to analyze categorical data to determine if there is a significant association between two variables.
- It is not suitable for comparing continuous variables like blood calcium levels.
*Linear regression*
- **Linear regression** is used to model the relationship between a dependent variable (outcome) and one or more independent variables (predictors).
- It aims to predict the value of a variable based on the value of another, rather than comparing means between groups.
*ANOVA (Analysis of Variance)*
- **ANOVA** is used to compare the means of **three or more independent groups**.
- Since there are only two groups being compared in this scenario, a t-test is more specific and appropriate.
*F-test*
- The **F-test** is primarily used to compare the variances of two populations or to assess the overall significance of a regression model.
- While it is the basis for ANOVA, it is not the direct test for comparing the means of two groups.
Question 6: You conduct a medical research study to determine the screening efficacy of a novel serum marker for colon cancer. The study is divided into 2 subsets. In the first, there are 500 patients with colon cancer, of which 450 are found positive for the novel serum marker. In the second arm, there are 500 patients who do not have colon cancer, and only 10 are found positive for the novel serum marker. What is the overall sensitivity of this novel test?
A. 450 / (450 + 10)
B. 490 / (10 + 490)
C. 490 / (50 + 490)
D. 450 / (450 + 50) (Correct Answer)
E. 490 / (450 + 490)
Explanation: ***450 / (450 + 50)***
- **Sensitivity** is defined as the proportion of actual positive cases that are correctly identified by the test.
- In this study, there are **500 patients with colon cancer** (actual positives), and **450 of them tested positive** for the marker, while **50 tested negative** (500 - 450 = 50). Therefore, sensitivity = 450 / (450 + 50) = 450/500 = 0.9 or 90%.
*450 / (450 + 10)*
- This formula represents **Positive Predictive Value (PPV)**, which is the probability that a person with a positive test result actually has the disease.
- It incorrectly uses the total number of **test positives** in the denominator (450 true positives + 10 false positives) instead of the total number of diseased individuals, which is needed for sensitivity.
*490 / (10 + 490)*
- This is actually the correct formula for **specificity**, not sensitivity.
- Specificity = TN / (FP + TN) = 490 / (10 + 490) = 490/500 = 0.98 or 98%, which measures the proportion of actual negative cases correctly identified.
- The question asks for sensitivity, not specificity.
*490 / (50 + 490)*
- This formula incorrectly mixes **true negatives (490)** with **false negatives (50)** in an attempt to calculate specificity.
- The correct specificity formula should use false positives (10), not false negatives (50), in the denominator: 490 / (10 + 490).
*490 / (450 + 490)*
- This calculation incorrectly combines **true negatives (490)** and **true positives (450)** in the denominator, which does not correspond to any standard epidemiological measure.
- Neither sensitivity nor specificity uses both true positives and true negatives in the denominator.
Question 7: A pharmaceutical corporation is developing a research study to evaluate a novel blood test to screen for breast cancer. They enrolled 800 patients in the study, half of which have breast cancer. The remaining enrolled patients are age-matched controls who do not have the disease. Of those in the diseased arm, 330 are found positive for the test. Of the patients in the control arm, only 30 are found positive. What is this test’s sensitivity?
A. 330 / (330 + 30)
B. 330 / (330 + 70) (Correct Answer)
C. 370 / (30 + 370)
D. 370 / (70 + 370)
E. 330 / (400 + 400)
Explanation: ***330 / (330 + 70)***
- **Sensitivity** measures the proportion of actual **positives** that are correctly identified as such.
- In this study, there are **400 diseased patients** (half of 800). Of these, 330 tested positive (true positives), meaning 70 tested negative (false negatives). So sensitivity is **330 / (330 + 70)**.
*330 / (330 + 30)*
- This calculation represents the **positive predictive value**, which is the probability that subjects with a positive screening test truly have the disease. It uses **true positives / (true positives + false positives)**.
- It does not correctly calculate **sensitivity**, which requires knowing the total number of diseased individuals.
*370 / (30 + 370)*
- This expression is attempting to calculate **specificity**, which is the proportion of actual negatives that are correctly identified. It would be **true negatives / (true negatives + false positives)**.
- However, the numbers used are incorrect for specificity in this context given the data provided.
*370 / (70 + 370)*
- This formula is an incorrect combination of values and does not represent any standard epidemiological measure like **sensitivity** or **specificity**.
- It is attempting to combine false negatives (70) and true negatives (370 from control arm) in a non-standard way.
*330 / (400 + 400)*
- This calculation attempts to divide true positives by the total study population (800 patients).
- This metric represents the **prevalence of true positives within the entire study cohort**, not the test's **sensitivity**.
Question 8: A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient’s concern?
A. CD4+ T cell count
B. Viral culture
C. Polymerase chain reaction (PCR) for HIV RNA (Correct Answer)
D. Antigen assay for p24
E. EIA for HIV antibody
Explanation: ***Polymerase chain reaction (PCR) for HIV RNA***
- **PCR for HIV RNA** directly detects the viral genetic material, providing a definitive diagnosis of HIV infection in an infant.
- Unlike antibody tests, PCR can distinguish between passively acquired maternal antibodies and actual infant infection, making it suitable for newborns.
*CD4+ T cell count*
- **CD4+ T cell count** is used to monitor the progression of HIV infection and immunosuppression, not for initial diagnosis, especially in neonates.
- While it's an important marker for HIV disease, it does not confirm the presence of the virus itself in a newborn.
*Viral culture*
- **Viral culture** is a highly specific method for detecting HIV, but it is expensive, time-consuming, and technically demanding.
- It is not routinely used for rapid early diagnosis in neonates due to its practical limitations and the availability of faster, reliable alternatives like PCR.
*Antigen assay for p24*
- The **p24 antigen test** can detect early HIV infection in adults, but its sensitivity is lower in neonates compared to PCR, especially immediately after birth.
- It may not reliably detect infection in newborns due to low viral loads or the presence of maternal antibodies that complex the antigen.
*EIA for HIV antibody*
- An **EIA for HIV antibody** will detect maternal antibodies that have crossed the placenta, meaning it will be positive in nearly all infants born to HIV-positive mothers, regardless of the infant's infection status.
- This test cannot distinguish between passive maternal antibody transfer and true infant infection.
Question 9: A medical research study is beginning to evaluate the positive predictive value of a novel blood test for non-Hodgkin’s lymphoma. The diagnostic arm contains 700 patients with NHL, of which 400 tested positive for the novel blood test. In the control arm, 700 age-matched control patients are enrolled and 0 are found positive for the novel test. What is the PPV of this test?
A. 400 / (400 + 0) (Correct Answer)
B. 700 / (700 + 300)
C. 400 / (400 + 300)
D. 700 / (700 + 0)
E. 700 / (400 + 400)
Explanation: ***400 / (400 + 0) = 1.0 or 100%***
- The **positive predictive value (PPV)** is calculated as **True Positives / (True Positives + False Positives)**.
- In this scenario, **True Positives (TP)** are the 400 patients with NHL who tested positive, and **False Positives (FP)** are 0, as no control patients tested positive.
- This gives a PPV of 400/400 = **1.0 or 100%**, indicating that all patients who tested positive actually had the disease.
*700 / (700 + 300)*
- This calculation does not align with the formula for PPV based on the given data.
- The denominator `(700+300)` suggests an incorrect combination of various patient groups.
*400 / (400 + 300)*
- The denominator `(400+300)` incorrectly includes 300, which is the number of **False Negatives** (patients with NHL who tested negative), not False Positives.
- PPV focuses on the proportion of true positives among all positive tests, not all diseased individuals.
*700 / (700 + 0)*
- This calculation incorrectly uses the total number of patients with NHL (700) as the numerator, rather than the number of positive test results in that group.
- The numerator should be the **True Positives** (400), not the total number of diseased individuals.
*700 / (400 + 400)*
- This calculation uses incorrect values for both the numerator and denominator, not corresponding to the PPV formula.
- The numerator 700 represents the total number of patients with the disease, not those who tested positive, and the denominator incorrectly sums up values that don't represent the proper PPV calculation.
Question 10: You are tasked with analyzing the negative predictive value of an experimental serum marker for ovarian cancer. You choose to enroll 2,000 patients across multiple clinical sites, including both 1,000 patients with ovarian cancer and 1,000 age-matched controls. From the disease and control subgroups, 700 and 100 are found positive for this novel serum marker, respectively. Which of the following represents the NPV for this test?
A. 700 / (700 + 300)
B. 700 / (300 + 900)
C. 700 / (700 + 100)
D. 900 / (900 + 100)
E. 900 / (900 + 300) (Correct Answer)
Explanation: ***900 / (900 + 300)***
- The **Negative Predictive Value (NPV)** is the probability that a person with a **negative test result** does not have the disease. It is calculated as **true negatives (TN)** divided by the sum of true negatives and **false negatives (FN)**, i.e., TN / (TN + FN).
- In this scenario: there are 1,000 ovarian cancer patients, and 700 tested positive, meaning **300 tested negative (false negatives)**. There are 1,000 controls, and 100 tested positive, meaning **900 tested negative (true negatives)**. Therefore, NPV = 900 / (900 + 300).
*700 / (700 + 300)*
- This calculation represents the sensitivity of the test, which is the proportion of true positives among all individuals with the disease (700 true positives / 1000 diseased individuals).
- It does not account for the true negatives or false positives, which are crucial for determining predictive values.
*700 / (300 + 900)*
- This formula mixes elements and does not correspond to a standard measure of test validity.
- The numerator (700) is the number of true positives, and the denominator incorrectly combines false negatives (300) and true negatives (900).
*700 / (700 + 100)*
- This calculation represents the **Positive Predictive Value (PPV)**, which is the probability that a person with a **positive test result** actually has the disease (700 true positives / (700 true positives + 100 false positives)).
- It does not assess the negative predictive power of the test.
*900 / (900 + 100)*
- This calculation represents the **specificity** of the test, which is the proportion of true negatives among all individuals without the disease (900 true negatives / 1000 controls).
- While this involves true negatives, it does not account for false negatives, which are essential for calculating NPV.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
